NO305125B1 - Farmas°ytiske forbindelser - Google Patents
Farmas°ytiske forbindelserInfo
- Publication number
- NO305125B1 NO305125B1 NO931917A NO931917A NO305125B1 NO 305125 B1 NO305125 B1 NO 305125B1 NO 931917 A NO931917 A NO 931917A NO 931917 A NO931917 A NO 931917A NO 305125 B1 NO305125 B1 NO 305125B1
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- pharmaceutical compounds
- optionally substituted
- cycloalkyl
- alkyl groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929211379A GB9211379D0 (en) | 1992-05-29 | 1992-05-29 | Pharmaceutical compounds |
GB939309025A GB9309025D0 (en) | 1993-04-30 | 1993-04-30 | Pharmaceutical compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
NO931917D0 NO931917D0 (no) | 1993-05-26 |
NO931917L NO931917L (no) | 1993-11-30 |
NO305125B1 true NO305125B1 (no) | 1999-04-06 |
Family
ID=26300951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931917A NO305125B1 (no) | 1992-05-29 | 1993-05-26 | Farmas°ytiske forbindelser |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0582368B1 (fi) |
JP (1) | JP3219541B2 (fi) |
CN (1) | CN1043994C (fi) |
AT (1) | ATE198891T1 (fi) |
AU (1) | AU668159B2 (fi) |
CA (1) | CA2097016A1 (fi) |
CZ (1) | CZ282783B6 (fi) |
DE (1) | DE69329887T2 (fi) |
DK (1) | DK0582368T3 (fi) |
ES (1) | ES2153373T3 (fi) |
FI (1) | FI101538B (fi) |
GR (1) | GR3035587T3 (fi) |
HU (1) | HU218278B (fi) |
IL (1) | IL105827A (fi) |
MX (1) | MX9303124A (fi) |
MY (1) | MY109943A (fi) |
NO (1) | NO305125B1 (fi) |
NZ (1) | NZ247703A (fi) |
PT (1) | PT582368E (fi) |
RU (1) | RU2125574C1 (fi) |
TW (1) | TW268005B (fi) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457101A (en) * | 1994-06-03 | 1995-10-10 | Eli Lilly And Company | Thieno[1,5]benzoidiazepine use |
US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
CR5278A (es) | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
IL126063A (en) * | 1996-03-25 | 2002-04-21 | Lilly Co Eli | Medicinal products containing ulanzapine for the treatment of migraine pain |
CN1494907A (zh) * | 1996-03-25 | 2004-05-12 | 治疗疼痛的药物组合物 | |
CN1219878A (zh) * | 1996-03-25 | 1999-06-16 | 伊莱利利公司 | 治疗疼痛的方法 |
ZA978515B (en) * | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
AU720366B2 (en) | 1996-09-23 | 2000-06-01 | Eli Lilly And Company | Olanzapine dihydrate D |
ID21762A (id) * | 1996-09-24 | 1999-07-22 | Lilly Co Eli | Formulasi partikel bersaput |
US20140057303A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Antibodies to Olanzapine Haptens and Use Thereof |
EP3556759B1 (en) | 2012-08-21 | 2023-11-29 | Janssen Pharmaceutica NV | Haptens of paliperidone |
WO2014031665A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to quetiapine haptens and use thereof |
JP6374387B2 (ja) | 2012-08-21 | 2018-08-15 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンハプテンへの抗体及びその使用 |
CA2882615C (en) | 2012-08-21 | 2019-07-09 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine and use thereof |
CN104755479B (zh) | 2012-08-21 | 2016-11-09 | 詹森药业有限公司 | 利培酮和帕潘立酮的半抗原 |
JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
JP6131415B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ.ベー. | イムノアッセイに使用するためのクエチアピンのハプテン |
CN104736567B (zh) | 2012-08-21 | 2019-09-03 | 詹森药业有限公司 | 阿立哌唑半抗原的抗体及其用途 |
PT2888269T (pt) * | 2012-08-21 | 2019-01-17 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
PT2888234T (pt) | 2012-08-21 | 2018-02-22 | Janssen Pharmaceutica Nv | Haptenos de aripiprazol e seu uso em imunoensaios |
CA2882490A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc. | Antibodies to paliperidone and use thereof |
TR201816416T4 (tr) | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
ES2762105T3 (es) | 2012-08-21 | 2020-05-22 | Janssen Pharmaceutica Nv | Anticuerpos para aripiprazol y uso de los mismos |
CN104755928B (zh) | 2012-08-21 | 2017-05-10 | 詹森药业有限公司 | 奥氮平的抗体及其用途 |
WO2017106508A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to quetiapine and use thereof |
CA3008809A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to risperidone and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU629879A3 (ru) * | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
FI762646A (fi) * | 1975-09-24 | 1977-03-25 | Sandoz Ag | |
GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1993
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 PT PT93304102T patent/PT582368E/pt unknown
- 1993-05-26 AT AT93304102T patent/ATE198891T1/de not_active IP Right Cessation
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-26 ES ES93304102T patent/ES2153373T3/es not_active Expired - Lifetime
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-26 DK DK93304102T patent/DK0582368T3/da active
- 1993-05-26 DE DE69329887T patent/DE69329887T2/de not_active Expired - Fee Related
- 1993-05-26 NO NO931917A patent/NO305125B1/no not_active IP Right Cessation
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-27 MX MX9303124A patent/MX9303124A/es not_active IP Right Cessation
- 1993-05-28 FI FI932445A patent/FI101538B/fi active
- 1993-05-28 CN CN93108212A patent/CN1043994C/zh not_active Expired - Fee Related
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 IL IL10582793A patent/IL105827A/xx not_active IP Right Cessation
- 1993-05-28 RU RU93005057A patent/RU2125574C1/ru active
- 1993-05-28 JP JP12642993A patent/JP3219541B2/ja not_active Expired - Fee Related
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/cs not_active IP Right Cessation
- 1993-05-28 HU HU9301579A patent/HU218278B/hu not_active IP Right Cessation
-
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUT66180A (en) | 1994-09-28 |
NZ247703A (en) | 1995-07-26 |
NO931917L (no) | 1993-11-30 |
RU2125574C1 (ru) | 1999-01-27 |
DE69329887D1 (de) | 2001-03-01 |
GR3035587T3 (en) | 2001-06-29 |
FI932445A (fi) | 1993-11-30 |
AU668159B2 (en) | 1996-04-26 |
HU218278B (en) | 2000-07-28 |
FI101538B1 (fi) | 1998-07-15 |
CN1043994C (zh) | 1999-07-07 |
EP0582368A1 (en) | 1994-02-09 |
IL105827A (en) | 1997-02-18 |
IL105827A0 (en) | 1993-09-22 |
PT582368E (pt) | 2001-05-31 |
NO931917D0 (no) | 1993-05-26 |
CZ282783B6 (cs) | 1997-10-15 |
HU9301579D0 (en) | 1993-09-28 |
CZ102493A3 (en) | 1993-12-15 |
FI101538B (fi) | 1998-07-15 |
MY109943A (en) | 1997-10-31 |
DE69329887T2 (de) | 2001-05-23 |
EP0582368B1 (en) | 2001-01-24 |
JPH0687862A (ja) | 1994-03-29 |
MX9303124A (es) | 1993-11-01 |
TW268005B (fi) | 1996-01-11 |
ES2153373T3 (es) | 2001-03-01 |
FI932445A0 (fi) | 1993-05-28 |
ATE198891T1 (de) | 2001-02-15 |
AU3980793A (en) | 1993-12-02 |
JP3219541B2 (ja) | 2001-10-15 |
CN1085903A (zh) | 1994-04-27 |
DK0582368T3 (da) | 2001-02-05 |
CA2097016A1 (en) | 1993-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305125B1 (no) | Farmas°ytiske forbindelser | |
KR930703355A (ko) | 항생물질 ge2270 인자의 아미드 | |
KR870700620A (ko) | 신규 약리학적 화합물 | |
CZ284872B6 (cs) | Cyklické močoviny a jejich analogy a farmaceutické přípravky na jejich bázi | |
DK0674513T3 (da) | Retroviral protease-inhiberende forbindelser | |
PH25859A (en) | Composition for treatment of ischemic disorder | |
ES2143526T3 (es) | Derivados de amida que tienen actividad antihipercolesterolemica, su preparacion y sus usos terapeuticos. | |
DE69231661T2 (de) | Antifungizide trisubstituierte tetrahydrofurane | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
SE9100920D0 (sv) | New active compounds | |
BR9503536A (pt) | Composto processo para sua preparação seu uso e composição farmacêutica | |
ATE117989T1 (de) | Prostaglandinanaloge enthaltende lipidemulsion. | |
FI891279A (fi) | Antivirala tetrahydroimidazol /1,4/ benzodiazepin-2-oner. | |
DE3371627D1 (en) | Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them | |
ATE145911T1 (de) | Inositol-phosphat-analog als kalzium- antagonistische substanz | |
TW275629B (fi) | ||
DE3867494D1 (de) | Fluor enthaltende vitamin-d2-derivate. | |
ES2037825T3 (es) | Uso farmaceutico de tioeteres aromaticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |